Skip to content
Screener

Encompass Health Corporation EHC Q4 2025 Annual earnings

Reported February 5, 2026 · After market close

Revenue$1.5BBeat by $5.1M
EPS$1.46Beat by $0.17
Revenue estimate$1.5B
EPS estimate$1.29

Next report

Oct 28, 2026 (in a month)
Revenue estimate$1.6B
EPS estimate$1.38

Financials

Q4 2025

Income statement

See full
Revenue$1.5B+9.9%
Net income$146.1M+20.8%
EPS (diluted)$1.43+21.2%

Balance sheet

See full
Cash & equivalents$102.9M-16.4%
Total debt$3.1B-3.7%
Total equity$2.4B+18.0%
Total assets$7.1B+8.5%

Cash flow

See full
Operating cash flow$346.0M+24.1%
CapEx$229.3M+15.4%
Free cash flow$116.7M+45.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$10.68B+14.8%
Enterprise value$13.63B+10.3%
P/E18.9×-1.6×
P/S1.8×+0.1×

Profitability

See full
Net margin9.5%+1.1pp
FCF margin7.4%+0.7pp

Returns & leverage

See full
Return on equity25.1%+0.6pp
Debt / equity1.3×-0.3×
Current ratio1.1×0.0×

Segments

By segment

See full
Inpatient Rehabilitation$1.5B+9.9%

FAQ

When did Encompass Health Corporation report Q4 2025 earnings?
Encompass Health Corporation (EHC) reported Q4 2025 earnings on February 5, 2026 after market close.
What were Encompass Health Corporation's Q4 2025 revenue and EPS?
Encompass Health Corporation reported revenue of $1.5B and eps of $1.46 for Q4 2025.
Did Encompass Health Corporation beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.5B by $5.1M. EPS beat the consensus estimate of $1.29 by $0.17.
How did Encompass Health Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.9% from $1.4B a year earlier and eps grew 24.8% from $1.17.
Where can I find Encompass Health Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000785161-26-000025) and the 10-K periodic report (0000785161-26-000081) directly on SEC EDGAR. The filing index links above go to sec.gov.